v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (332) $ (2,510)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation, amortization and impairment 1,167 1,215
Share-based compensation 981 1,360
Amortization of intangible assets 152 152
Capital loss 255
Amortization of issuance costs of Convertible debt 27 50
Changes in operating assets and liabilities:    
Decrease in accrued severance pay, net (4) (58)
Decrease in other assets, other receivables and prepaid expenses 1,424 717
Increase in accrued interest and amortization of premium on available-for-sale marketable securities (341) (372)
Decrease in operating lease right-of-use asset 304 552
Decrease in operating leases liability (143) (459)
Increase in trade receivables (2,752) (191)
Decrease in inventories 418 167
Increase (Decrease) in trade payables 75 (262)
Decrease in employees and payroll accruals (2,212) (3,486)
Increase in deferred revenues 2,263 1,370
Decrease (Increase) in other payables and accrued expenses 403 (554)
Net cash provided by (used in) operating activities 1,685 (2,309)
Cash flows from investing activities:    
Decrease in restricted deposits 303 704
Investment in short-term bank deposits (8,700)
Withdrawal in short-term bank deposits 7,250 10,000
Purchase of property and equipment (281) (429)
Investment in available-for sale marketable securities (28,976) (24,275)
Proceeds from maturity of available-for-sale marketable securities 22,400 24,835
Net cash provided by (used in) investing activities (8,004) 10,835
Cash flows from financing activities:    
Proceeds from exercise of share options 238
Net cash provided by financing activities 238
Increase (decrease) in cash and cash equivalents (6,081) 8,526
Cash and cash equivalents at the beginning of the period 16,142 14,192
Cash and cash equivalents at the end of the period $ 10,061 $ 22,718